National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 45434

History of Changes from the VAERS Wayback Machine

Already in VAERS on 12/31/2003

VAERS ID: 45434
VAERS Form:
Age:1.1
Sex:Female
Location:New York
Vaccinated:1992-08-18
Onset:1992-08-27
Submitted:1992-09-18
Entered:1992-09-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MMR II / MSD 0263V / 0 - / -

Administered by: Private      Purchased by: Unknown
Symptoms: FEVER, RASH, LEUKOCYTOSIS, ESR INC, ANEMIA

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: mild vaginitis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: WBC21.7, G84%, L/M16%; HCT 27.8%, plt311,000; ESR90;
CDC 'Split Type':

Write-up: fever & rash beginning 9 days p/MMR; as of 18SEP92 rash has become typical of JRA, ESR-90, fevers persist, on Ibuprofen;


Changed on 12/8/2009

VAERS ID: 45434 Before After
VAERS Form:
Age:1.1
Sex:Female
Location:New York
Vaccinated:1992-08-18
Onset:1992-08-27
Submitted:1992-09-18
Entered:1992-09-25 1992-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MMR II MEASLES + MUMPS + RUBELLA (MMR II) / MSD MERCK & CO. INC. 0263V / 0 - / -

Administered by: Private      Purchased by: Unknown Private
Symptoms: Anaemia, Leukocytosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, FEVER, RASH, LEUKOCYTOSIS, ESR INC, ANEMIA

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: mild vaginitis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: WBC21.7, G84%, L/M16%; HCT 27.8%, plt311,000; ESR90;
CDC 'Split Type':

Write-up: fever & rash beginning 9 days p/MMR; as of 18SEP92 rash has become typical of JRA, ESR-90, fevers persist, on Ibuprofen;


Changed on 5/14/2017

VAERS ID: 45434 Before After
VAERS Form:
Age:1.1
Sex:Female
Location:New York
Vaccinated:1992-08-18
Onset:1992-08-27
Submitted:1992-09-18
Entered:1992-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 0263V / 0 - / -

Administered by: Private      Purchased by: Private
Symptoms: Anaemia, Leukocytosis, Pyrexia, Rash, Red blood cell sedimentation rate increased

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness: mild vaginitis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: WBC21.7, G84%, L/M16%; HCT 27.8%, plt311,000; ESR90;
CDC 'Split Type':

Write-up: fever & rash beginning 9 days p/MMR; as of 18SEP92 rash has become typical of JRA, ESR-90, fevers persist, on Ibuprofen;


Changed on 9/14/2017

VAERS ID: 45434 Before After
VAERS Form:(blank) 1
Age:1.1
Sex:Female
Location:New York
Vaccinated:1992-08-18
Onset:1992-08-27
Submitted:1992-09-18
Entered:1992-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 0263V / 0 1 - / -

Administered by: Private      Purchased by: Private
Symptoms: Anaemia, Leukocytosis, Pyrexia, Rash, Red blood cell sedimentation rate increased

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness: mild vaginitis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: WBC21.7, G84%, L/M16%; HCT 27.8%, plt311,000; ESR90;
CDC 'Split Type':

Write-up: fever & rash beginning 9 days p/MMR; as of 18SEP92 rash has become typical of JRA, ESR-90, fevers persist, on Ibuprofen;


Changed on 2/14/2018

VAERS ID: 45434 Before After
VAERS Form:1
Age:1.1
Sex:Female
Location:New York
Vaccinated:1992-08-18
Onset:1992-08-27
Submitted:1992-09-18
Entered:1992-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 0263V / 1 - / -

Administered by: Private      Purchased by: Private
Symptoms: Anaemia, Leukocytosis, Pyrexia, Rash, Red blood cell sedimentation rate increased

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness: mild vaginitis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: WBC21.7, G84%, L/M16%; HCT 27.8%, plt311,000; ESR90;
CDC 'Split Type':

Write-up: fever & rash beginning 9 days p/MMR; as of 18SEP92 rash has become typical of JRA, ESR-90, fevers persist, on Ibuprofen;


Changed on 6/14/2018

VAERS ID: 45434 Before After
VAERS Form:1
Age:1.1
Sex:Female
Location:New York
Vaccinated:1992-08-18
Onset:1992-08-27
Submitted:1992-09-18
Entered:1992-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 0263V / 1 - / -

Administered by: Private      Purchased by: Private
Symptoms: Anaemia, Leukocytosis, Pyrexia, Rash, Red blood cell sedimentation rate increased

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness: mild vaginitis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: WBC21.7, G84%, L/M16%; HCT 27.8%, plt311,000; ESR90;
CDC 'Split Type':

Write-up: fever & rash beginning 9 days p/MMR; as of 18SEP92 rash has become typical of JRA, ESR-90, fevers persist, on Ibuprofen;


Changed on 8/14/2018

VAERS ID: 45434 Before After
VAERS Form:1
Age:1.1
Sex:Female
Location:New York
Vaccinated:1992-08-18
Onset:1992-08-27
Submitted:1992-09-18
Entered:1992-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 0263V / 1 - / -

Administered by: Private      Purchased by: Private
Symptoms: Anaemia, Leukocytosis, Pyrexia, Rash, Red blood cell sedimentation rate increased

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness: mild vaginitis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: WBC21.7, G84%, L/M16%; HCT 27.8%, plt311,000; ESR90;
CDC 'Split Type':

Write-up: fever & rash beginning 9 days p/MMR; as of 18SEP92 rash has become typical of JRA, ESR-90, fevers persist, on Ibuprofen;


Changed on 9/14/2018

VAERS ID: 45434 Before After
VAERS Form:1
Age:1.1
Sex:Female
Location:New York
Vaccinated:1992-08-18
Onset:1992-08-27
Submitted:1992-09-18
Entered:1992-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 0263V / 1 - / -

Administered by: Private      Purchased by: Private
Symptoms: Anaemia, Leukocytosis, Pyrexia, Rash, Red blood cell sedimentation rate increased

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness: mild vaginitis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: WBC21.7, G84%, L/M16%; HCT 27.8%, plt311,000; ESR90;
CDC 'Split Type':

Write-up: fever & rash beginning 9 days p/MMR; as of 18SEP92 rash has become typical of JRA, ESR-90, fevers persist, on Ibuprofen;


Changed on 10/14/2018

VAERS ID: 45434 Before After
VAERS Form:1
Age:1.1
Sex:Female
Location:New York
Vaccinated:1992-08-18
Onset:1992-08-27
Submitted:1992-09-18
Entered:1992-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. 0263V / 1 - / -

Administered by: Private      Purchased by: Private
Symptoms: Anaemia, Leukocytosis, Pyrexia, Rash, Red blood cell sedimentation rate increased

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 4     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness: mild vaginitis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: WBC21.7, G84%, L/M16%; HCT 27.8%, plt311,000; ESR90;
CDC 'Split Type':

Write-up: fever & rash beginning 9 days p/MMR; as of 18SEP92 rash has become typical of JRA, ESR-90, fevers persist, on Ibuprofen;

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=45434&WAYBACKHISTORY=ON


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166